Warm needle acupuncture for osteoarthritis: A systematic review and meta-analysis

• Published in: Phytomedicine (Stuttgart) 2022-11, Vol.106, p.154388-154388, Article 154388
• Main Authors: Jun, Ji Hee, Choi, Tae-Young, Robinson, Nicola, Park, Ji-Yeun, Jun, Eun-Young, Kim, Kyeong Han, Lee, Hye Won, Lee, Myeong Soo, Park, Sunju
• Format: Article
• Language: English
• Subjects: Acupuncture; Function; Moxibustion; Osteoarthritis; Pain
• ISSN: 0944-7113; 1618-095X
• DOI: 10.1016/j.phymed.2022.154388

•Warm needle acupuncture (WA) is widely used for the treatment of osteoarthritis (OA) in East Asian countries.•A comprehensive systematic review and meta-analysis was conducted using fourteen databases.•WA was superior to drug therapy for the treatment of OA, reducing pain and improving both the total effective rate and function.•WA combined with drug therapy or intra-articular injection was superior to drug therapy or intra-articular injection alone for the treatment of OA, reducing pain and improving both the total effective rate and function. Warm needle acupuncture (WA) is considered a potential intervention in the treatment of osteoarthritis (OA). To systematically evaluate the clinical efficacy and safety of WA in the treatment of OA. Systematic review and meta-analysis Fourteen databases were searched from their inception until May 2022. Randomized controlled trials (RCTs) of WA for treating OA were identified. Study selection and data extraction were performed by two independent reviewers. The Cochrane risk of bias tool and the Grading of Recommendations Assessment, Development and Evaluation program were used to assess all included RCTs. A total of 66 RCTs met the inclusion criteria for this review. Most of the included studies had an unclear risk of bias, and the certainty of the evidence was very low. Twenty-four RCTs compared the effects of WA with those of oral drug therapies. Meta-analysis showed superior effects of WA for the total effective rate (risk ratio (RR): 1.22, 95% confidence interval (CI): 1.17 to 1.27, I2 = 26%, p < 0.001, 24 studies, n = 2278), pain, and function. Eight RCTs compared the effects of WA+drug therapy, and meta-analysis showed favorable effects for the total effective rate (RR: 1.27, 95% CI: 1.18 to 1.35, I2 =0%, p < 0.001, 8 studies, n = 646). Eight RCTs compared the effects of WA and intra-articular sodium hyaluronate (IASH) injection on OA and found equivalent effects of WA on the symptoms of OA. Twenty-eight RCTs compared the effects of WA+IASH injection with those of IASH injection, and meta-analysis showed superior effects of WA+IASH in terms of the total effective rate (RR: 1.15, 95% CI: 1.11 to 1.19, I2 =27.3%, p < 0.001, 25 studies, n = 2208), pain, and function. None of the RCTs reported serious adverse events. WA may have some distinct advantages in the treatment of OA. However, well-designed RCTs with larger sample sizes are needed. [Display omitted]